
Corticosteroids Therapy Market by Type (Glucocorticoids, Mineralocorticoids), Route of Administration (Inhaled, Oral, Systemic), Application - Global Forecast 2024-2030
Description
Corticosteroids Therapy Market by Type (Glucocorticoids, Mineralocorticoids), Route of Administration (Inhaled, Oral, Systemic), Application - Global Forecast 2024-2030
The Corticosteroids Therapy Market size was estimated at USD 4.97 billion in 2023 and expected to reach USD 5.26 billion in 2024, at a CAGR 7.48% to reach USD 8.24 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Corticosteroids Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Corticosteroids Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Corticosteroids Therapy Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Allergan PLC by AbbVie Inc., Amgen Inc., AstraZeneca PLC, Biogen Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Cipla Inc., Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Galderma Group, Gilead Sciences, Inc., GlaxoSmithKline PLC, Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A., SANTHERA PHARMACEUTICALS, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..
Market Segmentation & Coverage
This research report categorizes the Corticosteroids Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Glucocorticoids
Mineralocorticoids
Route of Administration
Inhaled
Oral
Systemic
Topical
Application
Acute Respiratory Diseases
Endocrinology
Gastroenterology
Rheumatology
Skin Allergies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Corticosteroids Therapy Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Corticosteroids Therapy Market?
3. What are the technology trends and regulatory frameworks in the Corticosteroids Therapy Market?
4. What is the market share of the leading vendors in the Corticosteroids Therapy Market?
5. Which modes and strategic moves are suitable for entering the Corticosteroids Therapy Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
188 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Corticosteroids Therapy Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of inflammatory and autoimmune diseases
- 5.1.1.2. Availability of drug delivery systems with improved convenience and efficacy
- 5.1.1.3. Therapeutic applications of corticosteroids-therapy in infectious diseases
- 5.1.2. Restraints
- 5.1.2.1. Availability of alternative therapies
- 5.1.3. Opportunities
- 5.1.3.1. Introduction of novel injectable carrier-based corticosteroid therapy
- 5.1.3.2. Improvements in single-entity inhaled corticosteroid therapy
- 5.1.4. Challenges
- 5.1.4.1. Adverse effects associated with corticosteroids-therapy
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Corticosteroids Therapy Market, by Type
- 6.1. Introduction
- 6.2. Glucocorticoids
- 6.3. Mineralocorticoids
- 7. Corticosteroids Therapy Market, by Route of Administration
- 7.1. Introduction
- 7.2. Inhaled
- 7.3. Oral
- 7.4. Systemic
- 7.5. Topical
- 8. Corticosteroids Therapy Market, by Application
- 8.1. Introduction
- 8.2. Acute Respiratory Diseases
- 8.3. Endocrinology
- 8.4. Gastroenterology
- 8.5. Rheumatology
- 8.6. Skin Allergies
- 9. Americas Corticosteroids Therapy Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Corticosteroids Therapy Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Corticosteroids Therapy Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Allergan PLC by AbbVie Inc.
- 13.1.3. Amgen Inc.
- 13.1.4. AstraZeneca PLC
- 13.1.5. Biogen Inc.
- 13.1.6. Boehringer Ingelheim GmbH
- 13.1.7. Bristol-Myers Squibb Company
- 13.1.8. Cipla Inc.
- 13.1.9. Dr. Reddy's Laboratories Ltd.
- 13.1.10. Eli Lilly and Company
- 13.1.11. Galderma Group
- 13.1.12. Gilead Sciences, Inc.
- 13.1.13. GlaxoSmithKline PLC
- 13.1.14. Lupin Pharmaceuticals, Inc.
- 13.1.15. Merck & Co., Inc.
- 13.1.16. Mylan N.V.
- 13.1.17. Novartis AG
- 13.1.18. Pfizer Inc.
- 13.1.19. Sanofi S.A.
- 13.1.20. SANTHERA PHARMACEUTICALS
- 13.1.21. Sun Pharmaceutical Industries Ltd.
- 13.1.22. Takeda Pharmaceutical Company Limited
- 13.1.23. Teva Pharmaceutical Industries Ltd.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. CORTICOSTEROIDS THERAPY MARKET RESEARCH PROCESS
- FIGURE 2. CORTICOSTEROIDS THERAPY MARKET SIZE, 2023 VS 2030
- FIGURE 3. CORTICOSTEROIDS THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. CORTICOSTEROIDS THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. CORTICOSTEROIDS THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. CORTICOSTEROIDS THERAPY MARKET DYNAMICS
- FIGURE 7. CORTICOSTEROIDS THERAPY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. CORTICOSTEROIDS THERAPY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
- FIGURE 10. CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. CORTICOSTEROIDS THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. CORTICOSTEROIDS THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. CORTICOSTEROIDS THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. CORTICOSTEROIDS THERAPY MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.